Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 32, Issue 1, Pages 968-977
Publisher
Informa UK Limited
Online
2017-07-18
DOI
10.1080/14756366.2017.1347163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease
- (2017) Lhassane Ismaili et al. PROGRESS IN NEUROBIOLOGY
- Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR)
- (2016) Patrícia Bacalhau et al. BIOORGANIC CHEMISTRY
- Steric and Dynamic Parameters Influencing In Situ Cycloadditions to Form Triazole Inhibitors with Crystalline Acetylcholinesterase
- (2016) Yves Bourne et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents
- (2016) Manjinder Singh et al. RSC Advances
- Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone–6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer’s disease
- (2015) Shixian Liao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease
- (2015) Zhipei Sang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Potential of aryl–urea–benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease
- (2015) Belma Zengin Kurt et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
- (2014) Tiago Silva et al. AGEING RESEARCH REVIEWS
- Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
- (2014) Natalia Guzior et al. CURRENT MEDICINAL CHEMISTRY
- A review on cholinesterase inhibitors for Alzheimer’s disease
- (2013) Preet Anand et al. ARCHIVES OF PHARMACAL RESEARCH
- Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase
- (2013) Florian Nachon et al. BIOCHEMICAL JOURNAL
- Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine–Homoisoflavonoid hybrids
- (2013) Yang Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Multifunctional tacrine–flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease
- (2013) Su-Yi Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutics of Alzheimer's disease: Past, present and future
- (2013) R. Anand et al. NEUROPHARMACOLOGY
- Homoisoflavonoids: Natural Scaffolds with Potent and Selective Monoamine Oxidase-B Inhibition Properties
- (2011) Nicoletta Desideri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease
- (2010) Cassia R. Overk et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Cholinesterase inhibitors and memory
- (2009) Giancarlo Pepeu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Geissospermum vellosii stembark
- (2009) Josélia A. Lima et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now